Just a couple weeks after announcing it's weighing “strategic alternatives,” Kronos Bio Inc. is losing its chief executive and laying off the majority of its workforce.
The biotech, which is based in San Mateo, California, and has a research facility in Cambridge, said it would cut its workforce around 83% by year end. Kronos (Nasdaq: KRON) reported 62 full-time employees as of March 11, meaning more than 50 employees could be let go.
WATCH ANYTIME FOR FREE
 |
Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter.
Copyright Boston Business Journal
